Increased leukemia-associated gene expression in benzene-exposed workers

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Li, Keqiu ^a   Jing, Yaqing ^a   Yang, Caihong ^a   Liu, Shasha ^b   Zhao, Yuxia ^a   He, Xiaobo ^a   Li, Fei ^a   Han, Jiayi ^a   Li, Guang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Central Hospital of Gynecology Obstetrics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; BSG PROTEIN, HUMAN; CARCINOGEN; CD147 ANTIGEN; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; CASE CONTROL STUDY; CHEMICALLY INDUCED; COPY NUMBER VARIATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OCCUPATIONAL EXPOSURE; UPREGULATION;

ADULT; ANTIGENS, CD147; BENZENE; CARCINOGENS; CARCINOGENS, ENVIRONMENTAL; CASE-CONTROL STUDIES; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RECEPTOR, NOTCH1; UP-REGULATION;

EID: 84903986617     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05369     Document Type: Article

References (48)

1. McHale, C. M., Zhang, L. & Smith, M. T. Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis 33, 240-252 (2012).
2. Wilbur, S. et al. ATSDR evaluation of potential for human exposure to benzene. Toxicol. Ind. Health. 24, 399-442 (2008).
3. Khalade, A., Jaakkola, M. S., Pukkala, E. & Jaakkola, J. J. Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ. Health. 9, 31 (2010).
4. Smith, M. T. Advances in understanding benzene health effects and susceptibility. Ann. Rev. Public Health. 31, 133-148 (2010).
5. Steinmaus, C., Smith, A. H., Jones, R.M. & Smith, M. T. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup. Environ. Med. 65, 371-378 (2008). (Pubitemid 351775796)
6. Lan, Q. et al. Hematotoxicity in Workers Exposed to Low Levels of Benzene. Science 306, 1774-1776 (2004). (Pubitemid 39601394)
7. Kasuba, V., Rozgaj, R.Sentija, K. Cytogenetic changes in subjects occupationally exposed to benzene. Chemosphere 40, 307-310 (2000). (Pubitemid 30016402)
8. Zhang, L. et al. Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers. Environ. Mol. Mutagen. 48, 467-474 (2007). (Pubitemid 47207005)
9. Zhang, L., Eastmond, D. A. & Smith, M. T. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit Rev Toxicol. 32, 1-42 (2002). (Pubitemid 34132781)
10. Smith, M. T. et al. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res. 58, 2176-2181 (1998). (Pubitemid 28232905)
11. Zhang, L. et al. Benzene increases aneuploidy in the lymphocytes of exposed workers: a comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells. Environ. Mol. Mutagen. 34, 260-268 (1999). (Pubitemid 30039042)
12. Smith, M. T. et al. Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis 21, 1485-1490 (2000). (Pubitemid 30608216)
13. Stillman, W. S., Varella-Garcia, M. & Irons, R. D. The benzene metabolite, hydroquinone, selectively induces 5q31-and-7 in human CD341CD19-bone marrow cells. Exp. Hematol. 28, 169-176 (2000). (Pubitemid 30100824)
14. Forrest, M. S. et al. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene exposed workers. Environ. Health Perspect. 113, 801-807 (2005). (Pubitemid 40862197)
15. McHale, C. M. et al. Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross comparison on two microarray platforms. Genomics 93, 343-349 (2009).
16. McHale, C. M. et al. Global gene expression profiling of a population exposed to a range of benzene levels. Environ. Health Perspect. 119, 628-634 (2010).
17. Feuk L., Carson, A. R. & Scherer, S. W. Structural variation in the humangenome. Nat. Rev. Genet. 7, 85-97 (2006)
18. Kim, K. I. et al. Copy number variations in normal karyotype acute myeloid leukemia and their association with treatment response. Basic Clin. Pharmacol. Toxicol. 111, 317-324 (2012).
19. Burkhardt, B. et al. Loss of heterozygosity on chromosome 6q14-q24 isassociated with poor outcome in children and adolescents with T-cell lymphoblasticlymphoma. Leukemia 20, 1422-1429 (2006). (Pubitemid 44084056)
20. Huse, K. et al. Geneticvariants of the copy number polymorphic beta-defensin locus are associated with sporadic prostate cancer. Tumour Biol. 29, 83-92 (2008).
21. Lin, L. J. et al. Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotidepolymorphismarray. Oncology 75, 102-112 (2008).
22. Wang, Z. C. et al. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res. 64, 64-71 (2004). (Pubitemid 38114083)
23. Yang, T. et al. Genome-wide Copy Number Variation Study: Identified a Susceptibility Gene, UGT2B17, for Osteoporosis. Am J Hum Genet. 83, 663-674 (2008).
24. Buckland, P. R. Polymorphically duplicated genes: their relevance to phenotypic variation in humans. Ann. Med. 35, 308-315 (2003). (Pubitemid 37013671)
25. Nguyen, D. Q., Webber, C. & Ponting, C. P. Bias of selection on human copynumber variants. PLoS Genet. 2, e20 (2006).
26. McCarroll, S. A. et al. Common deletion polymorphisms in the human genome. Nat. Genet. 38, 86-92 (2006). (Pubitemid 43011887)
27. Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444-454 (2006). (Pubitemid 44809057)
28. Lupski, J. R. Retrotransposition and structural variation in the human genome. Cell 356: 141, 1110-1112 (2010).
29. Vermeulen, R. et al. Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. Ann. Occup. Hyg. 48, 105-116 (2004). (Pubitemid 38374252)
30. Snyder, R. Leukemia and Benzene. Int J Environ Res Public Health 9, 2875-2893 (2012).
31. Vlierberghe, P. V. & Ferrando, A. The molecular basis of T cell acute lymphoblastic leukemia. J. Clin. Invest. 122, 3398-3406 (2012).
32. Beesley, A. H. et al. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br. J. Haematol. 131, 447-456 (2005). (Pubitemid 43899641)
33. Schoch, C. et al. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 19, 1224-1228 (2005). (Pubitemid 40946008)
34. Etienne, W. et al. Comparison of mRNA gene expression by RT-PCR and DNA microarray. Biotechniques 36, 618-626 (2004). (Pubitemid 38451646)
35. Grabher, C., Boehmer, H. V. & Look, A. T. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat. Rev. Cancer. 6, 347-359 (2006).
36. López, C. et al. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. Genes Chromosomes Cancer 51, 881-889 (2012).
37. Lin, C. et al. Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia. Cancer Cell Int. 12, 13 (2012).
38. Fabbri, G. et al. Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation. J. Exp. Med. 208, 1389-13401 (2011).
39. Put, N. et al. Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia. Leukemia 23, 1201-1204 (2009).
40. Rossi, D. et al.Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119, 521-529 (2012).
41. Tsai, W. C. et al. Increasing EMMPRIN and matriptase expression in hepatocellularcarcinoma: tissue microarrayanalysis of immunohistochemical scores with clinic opathological parameters. Histopathology 49, 388-395 (2006).
42. Biswas, C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem. Biophys. Res. Commun. 109, 1026-1034 (1982). (Pubitemid 13149714)
43. Biswas, C. et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995; 55, 434-439 (1995).
44. Guo, H. et al. Stimulation of matrixmetalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J. Biol. Chem. 272, 24-27 (1997). (Pubitemid 27021117)
45. Kataoka, H., DeCastro, R., Zucker, S. & Biswas, C. Tumor cell-derived collagenase stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer. Res. 53, 3154-3158 (1993). (Pubitemid 23210328)
46. DeCastro, R. et al. Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J. Invest. Dermatol. 106, 1260-1265 (1996).
47. Beesley, A. H. et al. The gene expression signature of relapse in paediatric acute lymphoblasticleukaemia: implications for mechanisms of therapy failure. Br. J. Haematol. 131, 447-456 (2005). (Pubitemid 43899641)
48. Beesley, A. H., Weller, R. E. & Kees, U. R. The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse. Br. J. Haematol. 142, 1000-1002 (2008).